Literature DB >> 22014924

Muscle relaxants allergy.

D G Peroni1, N Sansotta, R Bernardini, G Crisafulli, F Franceschini, C Caffarelli, A L Boner.   

Abstract

The most common agents that are responsible for intraoperative anaphylaxis are muscle relaxants. In fact, neuromuscular blocking agents (NMBAs) contribute to 50-70 percent of allergic reactions during anaesthesia. The main mechanism of hypersensitivity reactions to NMBAs is represented by acute type I allergic reactions and the most severe form is anaphylaxis. The rate of non IgE mediated immediate hypersensitivity reactions usually varies between 20 percent and 35 percent of the reported cases in most large series. In a recent report, non allergic suspected reactions to NMBAs occurred with almost the same frequency as did those with an allergic component. Although the precise mechanisms of these reactions remain difficult to ascertain, they usually result from direct non specific mast cell and basophil activation. After diagnostic procedures, regardless of the specific IgE results, NMBAs are contraindicated if the skin tests were positive. In view of the constantly evolving anesthesiologic practices, and of the complexity of allergy investigation, an active policy to identify patients at risk and to provide any necessary support to anaesthetists and allergologists should be promoted. The high frequency of IgE anaphylactic reactions and the feasibility of skin tests in children justify systematic allergy testing whenever hypersensitivity reaction occurs during general anaesthesia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22014924     DOI: 10.1177/03946320110240s306

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  2 in total

1.  Azemiopsin, a Selective Peptide Antagonist of Muscle Nicotinic Acetylcholine Receptor: Preclinical Evaluation as a Local Muscle Relaxant.

Authors:  Irina V Shelukhina; Maxim N Zhmak; Alexander V Lobanov; Igor A Ivanov; Alexandra I Garifulina; Irina N Kravchenko; Ekaterina A Rasskazova; Margarita A Salmova; Elena A Tukhovskaya; Vladimir A Rykov; Gulsara A Slashcheva; Natalya S Egorova; Inessa S Muzyka; Victor I Tsetlin; Yuri N Utkin
Journal:  Toxins (Basel)       Date:  2018-01-07       Impact factor: 4.546

2.  Anaphylaxis from atracurium without skin manifestation.

Authors:  Souvik Maitra; Suvadeep Sen; Sudeshna Bhar Kundu; Sugata Pal
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.